Please login to the form below

Not currently logged in
Email:
Password:

Dr Simon Chandler joins Ora as a senior director

He brings 15 years of ophthalmic industry experience 

Ora Simon ChandlerUS-based Ora, inc. has appointed Dr Simon Chandler as senior director, clinical research and regulatory operations.

Dr Chandler will be based at the pharmaceutical company's UK office and takes on responsibility for driving its European regulatory and clinical business.

He said: “I have personally experienced the quality, timely execution and strategic planning Ora delivers to ensure successful programs for their industry partners.

“I am proud to be joining a company with proven expertise in ophthalmology and a deep commitment to scientific rigor and innovation.”

He brings over 15 years of ophthalmic industry experience to the role, specialising in retina and anterior segment indications.

Prior to joining Ora, Dr Chandler served as principal of Sci-pHecta Consulting from 2013 and has also held leadership roles at Bausch + Lamb, Ista Pharmaceuticals, NightStaRx BioPharmaceuticals and Oxford BioMedica among others.

Ora's president and chief executive officer Stuart Abelson said: “Dr Chandler is a key addition to Ora's team and brings extensive experience in global clinical and regulatory operations, including overseeing approvals by the FDA, EMA and PMDA.

“His current experience in gene therapy is highly relevant given the potential of this new therapeutic modality to address unmet patient needs.”

5th April 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value: Patient Involvement in Health Technology Assessment
Exploring the evolution of patient involvement in health technology assessment (HTA), and the role of the patient voice in market access....

Infographics